<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (ABD) is a multi-system disorder with recurrent oral and/or <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulcerations</z:e>, <z:mp ids='MP_0001212'>skin lesions</z:mp> and ocular involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Eye involvement is a common manifestation that affects the patients' quality of life more than any other </plain></SENT>
<SENT sid="2" pm="."><plain>Left untreated, it leads to <z:hpo ids='HP_0000618'>blindness</z:hpo> and often to loss of the eye through secondary complications like <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">phthisis</z:e> or painful <z:hpo ids='HP_0000501'>glaucoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In some cases, such as <z:hpo ids='HP_0007917'>tractional retinal detachment</z:hpo>, secondary <z:hpo ids='HP_0000501'>glaucoma</z:hpo> or secondary <z:hpo ids='HP_0000518'>cataract</z:hpo> formation, intraocular surgery is required </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A prospective study of patients with ocular ABD who underwent intraocular surgery under systemic treatment with interferon-alpha was conducted </plain></SENT>
<SENT sid="5" pm="."><plain>From 1999 to 2005, we treated eight eyes from five patients with pars plana vitrectomy (n = 1), phacoemulsification (n = 6) and trabeculectomy (n = 1) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean follow-up was 49 months (range 5-94 months) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Seven out of eight eyes had better visual acuity following surgery </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0005163'>One eye</z:mp> did not benefit from <z:hpo ids='HP_0000518'>cataract</z:hpo> surgery because of <z:hpo ids='HP_0000648'>optic nerve atrophy</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Only <z:mp ids='MP_0005163'>one eye</z:mp> showed prolonged <z:mp ids='MP_0001845'>inflammation</z:mp> following phacoemulsification </plain></SENT>
<SENT sid="10" pm="."><plain>None of the patients showed a recurrence during follow-up </plain></SENT>
<SENT sid="11" pm="."><plain>The failure of conservative <z:hpo ids='HP_0000501'>glaucoma</z:hpo> treatment necessitated trabeculectomy in <z:mp ids='MP_0005163'>one eye</z:mp>; the patient has had no further recurrence for 6 years under monotherapy with interferon-alpha </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: Interferon-alpha is a potent therapy for Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with ocular involvement </plain></SENT>
<SENT sid="13" pm="."><plain>It also provides a basis for safe and reliable surgical interventions </plain></SENT>
<SENT sid="14" pm="."><plain>In seven of eight eyes, there was no intra- or peri-operative recurrence of <z:mp ids='MP_0001845'>inflammation</z:mp>, which is a common complication after these procedures </plain></SENT>
<SENT sid="15" pm="."><plain>Only <z:mp ids='MP_0005163'>one eye</z:mp> showed <z:hpo ids='HP_0011009'>acute</z:hpo> and prolonged <z:mp ids='MP_0001845'>inflammation</z:mp> following <z:hpo ids='HP_0000518'>cataract</z:hpo> surgery </plain></SENT>
</text></document>